Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Azurrx Biopharma Inc (AZRX)

3.44 -0.08 (-2.27%)

04-20 15:59

Open:

3.69

Pre. Close:

3.52

High:

3.6908

Low:

3.44

Volume:

11,714

Market Cap:

43M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.694 - 3.718

3.718 - 3.734

Low:

3.417 - 3.445

3.445 - 3.465

Close:

3.463 - 3.504

3.504 - 3.533

Technical analysis  (as of: 2018-04-20 4:27:41 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 4.37     One year: 5.11

Support:

Support1: 3.08    Support2: 2.67

Resistance:

Resistance1: 3.74    Resistance2: 4.37

Pivot:

3.23

Moving Averages:

MA(5): 3.52     MA(20): 3.21

MA(100): 3.14     MA(250): 3.48

MACD:

MACD(12,26): 0.14     Signal(12,26,9): 0.10

%K %D:

%K(14,3): 75.94     %D(3): 79.03

RSI:

RSI(14): 63.14

52-Week:

High: 5.25  Low: 2.31  Change(%): -8.9

Average Vol(K):

3-Month: 3968  10-Days 2222

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AZRX has closed below upper band by 21.4%. Bollinger Bands are 22% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-02-13T13:58:09-05:00
AzurRX Biopharma (AZRX) Presents At BIO CEO & Investor Conference - Slideshow

2018-01-30T13:54:48-05:00
AzurRx BioPharma up 13%

2018-01-21T02:53:39-05:00
Week 4 Breakout Forecast: Short-Term Picks To Give You An Edge

2018-01-13T12:44:46-05:00
Week 3 Breakout Forecast:  Short-Term Picks To Give You An Edge

2018-01-11T21:29:26-05:00
Breakout Portfolio Up 14.38% Into 2018: Method Or Madness?

2017-11-02T13:09:23-04:00
Equity offering registration roundup - healthcare

2017-09-29T11:27:38-04:00
Your Daily Pharma Scoop: Axovant's Promised Upside, Gilead's Whistleblower Trouble, PTCT Adcomm Negative

2017-09-27T10:02:18-04:00
AzurRx Bio's MS1819-SD shows treatment effect in mid-stage pancreatitis study; shares up

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

12.57

Shares Float (M)

12.05

% Held by Insiders

4.50

% Held by Institutions

21.50

Shares Short (K)

37

Shares Short Prior Month (K)

26

Stock Financials

EPS

EPS Est. Current Year

-0.850

EPS Est. Next Year

-0.670

EPS Est. Next Quarter

-0.160

Forward EPS

-0.640

Book Value (p.s.)

26.270

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-181.4

Return on Equity (ttm)

-455.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-7.18

Levered Free Cash Flow (M)

-4.42

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

0.13

P/S

P/CF

-6.13

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.